Development of cell markers for the identification and expansion of islet progenitor cells

Diabetes/Metabolism Research and Reviews

Volumn 19, Issue 5, 2003, Pages 363-374

  Zhang, You Qing ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Activins; Islet progenitor cell; Nestin; Regeneration; Transcription factor; Transdifferentiation

Indexed keywords

ACTIVIN; ADRENOMEDULLIN; CELL MARKER; GALACTOSIDASE; GENE PRODUCT; GLUCOSE TRANSPORTER 2; NESTIN; TYROSINE 3 MONOOXYGENASE; VIMENTIN;

CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL FATE; CELL ISOLATION; CELL LOSS; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENDOCRINE CELL; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; MEDICAL RESEARCH; NONHUMAN; ORGANOGENESIS; PANCREAS CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PURIFICATION; RETROSPECTIVE STUDY; REVIEW; STEM CELL; TISSUE CULTURE; TISSUE EXPANSION;

BIOLOGICAL MARKERS; CELL DIVISION; DIABETES MELLITUS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; REGENERATION; STEM CELLS; TISSUE DONORS; TISSUE EXPANSION;

EID: 0141501989     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.406     Document Type: Review

References (109)

1. Pictet R, Rutter WJ. Development of the embryonic pancreas. In Handbook of Physiology, vol. 1. Society AP, Steiner DF, Frenkel N (eds). Williams & Wilkins: Washington, DC, 1972; 25-66.
2. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE. A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 1993; 42: 1715-1720.
3. Fernandes A, King LC, Guz Y, Stein R, Wright CV, Teitelman G. Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology 1997; 138: 1750-1762.
4. Gu D, Sarvetnick N. Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice. Development 1993; 118: 33-46.
5. Gu D, Lee MS, Krahl T, Sarvetnick N. Transitional cells in the regenerating pancreas. Development 1994; 120: 1873-1881.
6. Rosenberg L, Vinik AI. Trophic stimulation of the ductular-islet cell axis: a new approach to the treatment of diabetes. Adv Exp Med Biol 1992; 321: 95-104.
7. Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 2000; 6: 278-282.
8. Peck AB, Cornelius JG, Chaudhari M, Shatz D, Ramiya VK. Use of in vitro-generated, stem cell-derived islets to cure type 1 diabetes: how close are we? Ann N Y Acad Sci 2002; 958: 59-68.
9. Madsen OD, Jensen J, Blume N, et al. Pancreatic development and maturation of the islet B cell. Studies of pluripotent islet cultures. Eur J Biochem 1996; 242: 435-445.
10. Rosenberg L. Induction of islet cell neogenesis in the adult pancreas: the partial duct obstruction model. Microsc Res Tech 1998; 43: 337-346.
11. Bonner-Weir S. Life and death of the pancreatic beta cells. Trends Endocrinol Metab 2000; 11: 375-378.
12. Bouwens L, Pipeleers DG. Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 1998; 41: 629-633.
13. Gu D, Sarvetnick N. A transgenic model for studying islet development. Recent Prog Horm Res 1994; 49: 161-165.
14. Guz Y, Nasir I, Teitelman G. Regeneration of pancreatic beta cells from intra-islet precursor cells in an experimental model of diabetes. Endocrinology 2001; 142: 4956-4968.
15. Zulewski H, Abraham EJ, Gerlach MJ, et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 2001; 50: 521-533.
16. Petropavlovskaia M, Rosenberg L. Identification and characterization of small cells in the adult pancreas: potential progenitor cells? Cell Tissue Res 2002; 310: 51-58.
17. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999; 283: 534-537.
18. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995; 18: 1417-1426.
19. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279: 1528-1530.
20. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705.
21. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science 284: 1168-1170.
22. Wang X, Al-Dhalimy M, Lagasse E, Finegold M, Grompe M. Liver repopulation and correction of metabolic liver disease by transplanted adult mouse pancreatic cells. Am J Pathol 2001; 158: 571-579.
23. Scarpelli DG, Rao MS. Differentiation of regenerating pancreatic cells into hepatocyte-like cells. Proc Natl Acad Sci USA 1981; 78: 2577-2581.
24. Bonner-Weir S, Taneja M, Weir GC, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 2000; 97: 7999-8004.
25. Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 2000; 6: 278-282.
26. Mashima H, Ohnishi H, Wakabayashi K, et al. Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J Clin Invest 1996; 97: 1647-1654.
27. Bouwens L, Pipeleers DG. Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 1998; 41: 629-633.
28. Gmyr V, Kerr-Conte J, Belaich S, et al. Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes 2000; 49: 1671-1680.
29. Yang L, Li S, Hatch H, et al. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA 2002; 99: 8078-8083.
30. Horb ME, Shen CN, Tosh D, Slack JM. Experimental conversion of liver to pancreas. Curr Biol 2003; 13: 105-115.
31. Tuch BE, Szymanska B, Yao M, et al. Function of a genetically modified human liver cell line that stores, processes and secretes insulin. Gene Ther 2003; 10: 490-503.
32. Kojima H, Fujimiya M, Matsumura. K, et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med 2003; 9: 596-603.
33. Yoshida S, Kajimoto Y, Yasuda T, et al. PDX-1 induces differentiation of intestinal epithelioid IEC-6 into insulin-producing cells. Diabetes 2002; 51: 2505-2513.
34. Ferber S, Halkin A, Cohen H, et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000; 6: 568-572.
35. Theise ND, Saxena R, Portmann BC, et al. The canals of Hering and hepatic stem cells in humans. Hepatology 1999; 30: 1425-1433.
36. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003; 111: 843-850.
37. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416: 542-545.
38. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature 2002; 416: 545-548.
39. Spees JL, Olson SD, Ylostalo J, et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA 2003; 100: 2397-2402.
40. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002; 297: 2256-2259.
41. Sauer B, Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci USA 1988; 85: 5166-5170.
42. Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988; 52: 773-782.
43. Kritzik MR, Krahl T, Good A, et al. Transcription factor expression during pancreatic islet regeneration. Mol Cell Endocrinol 2000; 164: 99-107.
44. Kritzik MR, Jones E, Chen Z, et al. PDX-1 and Msx-2 expression in the regenerating and developing pancreas. J Endocrinol 1999; 163: 523-530.
45. Krakowski M, Yeung B, Abdelmalik R, et al. IFN-gamma overexpression within the pancreas is not sufficient to rescue Pax4, Pax6, and Pdx-1 mutant mice from death. Pancreas 2000; 21: 399-340.
46. Sharma A, Zangen DH, Reitz P, et al. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 1999; 48: 507-513.
47. Rooman I, Heremans Y, Heimberg H, Bouwens L. Modulation of rat pancreatic acinoductal transdifferentiation and expression of PDX-1 in vitro. Diabetologia 2000; 43: 907-914.
48. Taguchi M, Yamaguchi T, Otsuki M. Induction of PDX-1-positive cells in the main duct during regeneration after acute necrotizing pancreatitis in rats. J Pathol 2002; 197: 638-646.
49. O'Reilly LA, Gu D, Sarvetnick N, et al. Alpha-Cell neogenesis in an animal model of IDDM. Diabetes 1997; 46: 599-606.
50. Arnush M, Gu D, Baugh C, et al. Growth factors in the regenerating pancreas of gamma-interferon transgenic mice. Lab Invest 1996; 74: 985-990.
51. Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 2000; 287: 1442-1446.
52. Soria B. In-vitro differentiation of pancreatic beta-cells. Differentiation 2001; 68: 205-219.
53. Edlund H. Pancreatic organogenesis-developmental mechanisms and implications for therapy. Nat Rev Genet 2002; 3: 524-532.
54. Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994; 371: 606-609.
55. Offield MF, Jetton TL, Labosky PA, et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996; 122: 983-995.
56. Swift GH, Liu Y, Rose SD, et al. An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2). Mol Cell Biol 1998; 18: 5109-5120.
57. Kim SK, Selleri L, Lee JS, et al. Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus. Nat Genet 2002; 30: 430-435.
58. Harrison KA, Thaler J, Pfaff SL, Gu H, Kehrl JH. Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice. Nat Genet 1999; 23: 71-75.
59. Li H, Arber S, Jessell TM, Edlund H. Selective agenesis of the dorsal pancreas in mice lacking homeobox gene Hlxb9. Nat Genet 1999; 23: 67-70.
60. Li H, Edlund H. Persistent expression of Hlxb9 in the pancreatic epithelium impairs pancreatic development. Dev Biol 2001; 240: 247-253.
61. Sussel L, Kalamaras J, Hartigan-O'Connor DJ, et al. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 1998; 125: 2213-2221.
62. St-Onge L, Sosa-Pineda B, Chowdhury K, Mansouri A, Gruss P. Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature 1997; 387: 406-409.
63. Sosa-Pineda B, Chowdhury K, Torres M, Oliver G, Gruss P. The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 1997; 386: 399-402.
64. Ahlgren U, Pfaff SL, Jessell TM, Edlund T, Edlund H. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 1997; 385: 257-260.
65. Schwitzgebel VM, Scheel DW, Conners JR, et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development 2000; 127: 3533-3542.
66. Gradwohl G, Dierich A, LeMeur M, Guillemot F. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 2000; 97: 1607-1611.
67. Naya FJ, Huang HP, Qiu Y, et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in Beta2/neuroD-deficient mice. Genes Dev 1997; 11: 2323-2334.
68. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002; 129: 2447-2457.
69. Cockell M, Stevenson BJ, Strubin M, Hagenbuchle O, Wellauer PK. Identification of a cell-specific DNA-binding activity that interacts with a transcriptional activator of genes expressed in the acinar pancreas. Mol Cell Biol 1989; 9: 2464-2476.
70. Krapp A, Knofler M, Frutiger S, Hughes GJ, Hagenbuchle O, Wellauer PK. The p48 DNA-binding subunit of transcription factor PTF1 is a new exocrine pancreas-specific basic helix-loop-helix protein EMBO J 1996; 15: 4317-4329.
71. Kawaguchi Y, Cooper B, Gannon M, Ray M, Mac Donald RJ, Wright CV. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet 2002; 32: 128-134.
72. Sander M, Sussel L, Conners J, et al. Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 2000; 127: 5533-5540.
73. Grapin-Botton A, Majithia AR, Melton DA. Key events of pancreas formation are triggered in gut endoderm by ectopic expression of pancreatic regulatory genes. Genes Dev 2001; 15: 444-454.
74. Jenny M, Uhl C, Roche C, et al. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J 2002; 21: 6338-6347.
75. Kojima H, Nakamura T, Fujita Y, et al. Diabetes 2002; 51: 1398-1440.
76. Upchurch BH, Aponte GW, Leiter AB. Expression of peptide YY in all four islet cell types in the developing mouse pancreas suggests a common peptide YY-producing progenitor. Development 1994; 120: 245-252.
77. Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000; 14: 627-644.
78. Hebrok M, Kim SK, Melton DA. Notochord repression of endodermal sonic hedgehog permits pancreas development. Genes Dev 1998; 12: 1705-1713.
79. Furukawa M, Eto Y, Kojima I. Expression of immunoreactive activin A in fetal rat pancreas. Endocr J 1995; 42: 63-68.
80. Maldonado TS, Kadison AS, Crisera CA, et al. Ontogeny of activin B and follistatin in developing embryonic mouse pancreas: implications for lineage selection. J Gastrointest Surg 2000; 4: 269-275.
81. Miralles F, Czernichow P, Scharfmann R. Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development. Development 1998; 125: 1017-1024.
82. Manova K, De Leon V, Angeles M, et al. mRNAs for activin receptors II and IIB are expressed in mouse oocytes and in the epiblast of pregastrula and gastrula stage mouse embryos. Mech Dev 1995; 49: 3-11.
83. Shiozaki S, Tajima T, Zhang YQ, Furukawa M, Nakazato Y, Kojima I. Impaired differentiation of endocrine and exocrine cells of the pancreas in transgenic mouse expressing the truncated type II activin receptor. Biochim Biophys Acta 1999; 1450: 1-11.
84. Yamaoka T, Idehara C, Yano M, et al. Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants. J Clin Invest 1998; 102: 294-301.
85. Kim SK, Hebrok M, Li E, et al. Activin receptor patterning of foregut organogenesis. Genes Dev 2000; 14: 1866-1871.
86. Zhang YQ, Zhang H, Maeshima A, et al. Up-regulation of the expression of activins in the pancreatic duct by reduction of the beta-cell mass. Endocrinology 2002; 143: 3540-3547.
87. Pour PM. Pancreatic centroacinar cells. The regulator of both exocrine and endocrine function. Int J Pancreatol 1994; 15: 51-64.
88. Bouwens L, De Blay E. Islet morphogenesis and stem cell markers in rat pancreas. J Histochem Cytochem 1996; 44: 947-951.
89. Anastasi E, Ponte E, Gradini R, et al. Expression of Reg and cytokeratin 20 during ductal cell differentiation and proliferation in a mouse model of autoimmune diabetes. Eur J Endocrinol 1999; 141: 644-652.
90. Demeterco C, Beattie GM, Dib SA, Lopez AD, Hayek A. A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endocrinol Metab 2000; 85: 3892-3897.
91. Zhang YQ, Mashima H, Kojima I. Changes in the expression of transcription factors in pancreatic AR42J cells during differentiation into insulin-producing cells. Diabetes 2001; 50(Suppl. 1): S10-S14.
92. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992; 255: 1707-1710.
93. Hunziker E, Stein M. Nestin-expressing cells in the pancreatic islets of Langerhans. Biochem Biophys Res Commun 2000; 271: 116-119.
94. Bonner-Weir S, Sharma A. Pancreatic stem cells. J Pathol 2002; 197: 519-526.
95. Selander L, Edlund H. Nestin is expressed in mesenchymal and not epithelial cells of the developing mouse pancreas. Mech Dev 2002; 113: 189-192.
96. Lardon J, Rooman I, Bouwens L. Nestin expression in pancreatic stellate cells and angiogenic endothelial cells. Histochem Cell Biol 2002; 117: 535-540.
97. Lechner A, Leech CA, Abraham EJ, Nolan AL, Habener JF. Nestin-positive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP-binding cassette transporter. Biochem Biophys Res Commun 2002; 293: 670-674.
98. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001; 292: 1389-1394.
99. Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 1989; 246: 670-673.
100. Yokoyama-Hayashi K, Takahashi T, Kakita A, Yamashina S. Expression of PGP9.5 in ductal cells of the rat pancreas during development and regeneration: can it be a marker for pancreatic progenitor cells? Endocr J 2000; 49: 61-74.
101. Rooman I, Lardon J, Bouwens L. Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes 2002; 51: 686-690.
102. Teitelman G, Lee JK. Cell lineage analysis of pancreatic islet development: glucagon and insulin cells arise from catecholaminergic precursors present in the pancreatic duct. Dev Biol 1987; 121: 454-466.
103. Page BJ, du Toit DF, Muller CJ, Mattysen J, Lyners R. An immunocytochemical profile of the endocrine pancreas using an occlusive duct ligation model. JOP 2000; 1: 191-203.
104. Percival AC, Slack JM. Analysis of pancreatic development using a cell lineage label. Exp Cell Res 1999; 247: 123-132.
105. Martinez A, Cuttitta F, Teitelman G. Expression pattern for adrenomedullin during pancreatic development in the rat reveals a common precursor with other endocrine cell types. Cell Tissue Res 1998; 293: 95-100.
106. Beattie GM, Levine F, Mally MI, et al. Acid beta-galactosidase: a developmentally regulated marker of endocrine cell precursors in the human fetal pancreas. J Clin Endocrinol Metab 1994; 78: 1232-1240.
107. Pang K, Mukonoweshuro C, Wong GG. Beta cells arise from glucose transporter type 2 (Glut2)-expressing epithelial cells of the developing rat pancreas. Proc Natl Acad Sci USA 1994; 91: 9559-9563.
108. Cras M, Kobayashi H, Spilde TL, et al. Lectin as a marker for staining and purification of embryonic pancreatic epithelium. Biochem Biophys Res Commun 2002; 293: 691-697.
109. Cras-Meneur C, Scharfmann R. FGFR1-IIIb is a putative marker of pancreatic progenitor cells. Mech Dev 2002; 116: 205-208.